JP2017505911A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017505911A5 JP2017505911A5 JP2016550860A JP2016550860A JP2017505911A5 JP 2017505911 A5 JP2017505911 A5 JP 2017505911A5 JP 2016550860 A JP2016550860 A JP 2016550860A JP 2016550860 A JP2016550860 A JP 2016550860A JP 2017505911 A5 JP2017505911 A5 JP 2017505911A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- antibody
- sample
- binding
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims 49
- 230000002380 cytological effect Effects 0.000 claims 18
- 238000000034 method Methods 0.000 claims 15
- 210000002919 epithelial cell Anatomy 0.000 claims 13
- 230000003211 malignant effect Effects 0.000 claims 10
- 238000011156 evaluation Methods 0.000 claims 9
- 201000011510 cancer Diseases 0.000 claims 5
- 238000000338 in vitro Methods 0.000 claims 4
- 210000002700 urine Anatomy 0.000 claims 4
- 238000000099 in vitro assay Methods 0.000 claims 2
- 210000004072 lung Anatomy 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 206010003445 Ascites Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000002151 Pleural effusion Diseases 0.000 claims 1
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 230000003302 anti-idiotype Effects 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 210000003719 b-lymphocyte Anatomy 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000000481 breast Anatomy 0.000 claims 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims 1
- 210000003679 cervix uteri Anatomy 0.000 claims 1
- 210000001072 colon Anatomy 0.000 claims 1
- 210000004443 dendritic cell Anatomy 0.000 claims 1
- 210000003979 eosinophil Anatomy 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 210000003714 granulocyte Anatomy 0.000 claims 1
- 210000003630 histaminocyte Anatomy 0.000 claims 1
- 210000004185 liver Anatomy 0.000 claims 1
- 210000001165 lymph node Anatomy 0.000 claims 1
- 210000002540 macrophage Anatomy 0.000 claims 1
- 210000000440 neutrophil Anatomy 0.000 claims 1
- 210000001672 ovary Anatomy 0.000 claims 1
- 210000000496 pancreas Anatomy 0.000 claims 1
- 210000004180 plasmocyte Anatomy 0.000 claims 1
- 210000003296 saliva Anatomy 0.000 claims 1
- 210000001625 seminal vesicle Anatomy 0.000 claims 1
- 210000001685 thyroid gland Anatomy 0.000 claims 1
- 201000010653 vesiculitis Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2014900494A AU2014900494A0 (en) | 2014-02-17 | Methods of detecting cancer | |
| AU2014900494 | 2014-02-17 | ||
| PCT/AU2015/050060 WO2015120523A1 (en) | 2014-02-17 | 2015-02-17 | Method of detecting cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017505911A JP2017505911A (ja) | 2017-02-23 |
| JP2017505911A5 true JP2017505911A5 (enExample) | 2018-03-29 |
| JP6685229B2 JP6685229B2 (ja) | 2020-04-22 |
Family
ID=53799455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016550860A Active JP6685229B2 (ja) | 2014-02-17 | 2015-02-17 | 癌を検出する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10338072B2 (enExample) |
| EP (1) | EP3108256B1 (enExample) |
| JP (1) | JP6685229B2 (enExample) |
| CN (1) | CN106461666B (enExample) |
| AU (1) | AU2015218188B2 (enExample) |
| DK (1) | DK3108256T3 (enExample) |
| ES (1) | ES2818089T3 (enExample) |
| IL (1) | IL247270B (enExample) |
| WO (1) | WO2015120523A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10338072B2 (en) | 2014-02-17 | 2019-07-02 | Sienna Cancer Diagnostics Ltd | Method of detecting cancer |
| CN107949791A (zh) * | 2015-08-19 | 2018-04-20 | 希艾娜癌症诊疗有限公司 | 癌症检测方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09262100A (ja) * | 1996-03-27 | 1997-10-07 | Mount Sinai School Medicine City Univ New York | テロメラーゼ活性の存在を測定することによる尿試料中のヒト膀胱癌細胞の検出方法 |
| US6939670B2 (en) | 2001-03-12 | 2005-09-06 | Monogen, Inc. | Cell-based detection and differentiation of lung cancer |
| CA2598179A1 (en) * | 2005-02-18 | 2006-08-24 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Office Of Technology Transfer, National Institutes Of Health | Methods for detecting progression of low grade cervical dysplasia and for detecting adenocarcinomas |
| US20090142259A1 (en) * | 2006-05-12 | 2009-06-04 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors |
| WO2009075803A2 (en) * | 2007-12-05 | 2009-06-18 | The Johns Hopkins University | Alternative splice variant patterns of human telomerase reverse transcriptase (htert) in thyroid tumors to distinguish benign from malignant |
| US10338072B2 (en) | 2014-02-17 | 2019-07-02 | Sienna Cancer Diagnostics Ltd | Method of detecting cancer |
| CN107949791A (zh) | 2015-08-19 | 2018-04-20 | 希艾娜癌症诊疗有限公司 | 癌症检测方法 |
-
2015
- 2015-02-17 US US15/116,182 patent/US10338072B2/en active Active
- 2015-02-17 AU AU2015218188A patent/AU2015218188B2/en active Active
- 2015-02-17 ES ES15748774T patent/ES2818089T3/es active Active
- 2015-02-17 CN CN201580008934.2A patent/CN106461666B/zh active Active
- 2015-02-17 WO PCT/AU2015/050060 patent/WO2015120523A1/en not_active Ceased
- 2015-02-17 EP EP15748774.5A patent/EP3108256B1/en active Active
- 2015-02-17 JP JP2016550860A patent/JP6685229B2/ja active Active
- 2015-02-17 DK DK15748774.5T patent/DK3108256T3/da active
-
2016
- 2016-08-14 IL IL247270A patent/IL247270B/en active IP Right Grant
-
2019
- 2019-05-20 US US16/417,042 patent/US11391738B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zahel et al. | Phenotyping of pulmonary carcinoids and a Ki-67-based grading approach | |
| Shao et al. | Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer | |
| JP2017518366A5 (enExample) | ||
| Pathmanathan et al. | Ki67 and proliferation in breast cancer | |
| Slater et al. | LCN2 and TIMP1 as potential serum markers for the early detection of familial pancreatic cancer | |
| Broersen et al. | Clinical application of circulating tumor cells in breast cancer | |
| Lin | Integrated EpCAM-independent subtraction enrichment and iFISH strategies to detect and classify disseminated and circulating tumors cells | |
| Crosbie et al. | Prognostic and predictive biomarkers in early stage NSCLC: CTCs and serum/plasma markers | |
| JP2014524744A5 (enExample) | ||
| JP2018535404A5 (enExample) | ||
| RU2017119009A (ru) | Анализы для обнаружения субпопуляций иммунных т-клеток и способы их применения | |
| JP2012073260A5 (enExample) | ||
| JP5370826B2 (ja) | 癌の組織型を判別するカクテル抗体、判別キット及び判別方法 | |
| Zhu et al. | High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma | |
| Sheng et al. | Comparison of analytic performances of Cellsearch and iFISH approach in detecting circulating tumor cells | |
| JP2017532577A5 (enExample) | ||
| Conner et al. | HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies | |
| Jiang et al. | Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors | |
| Asch-Kendrick et al. | NKX3. 1 is expressed in ER-positive and AR-positive primary breast carcinomas | |
| Troppan et al. | The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma | |
| Su et al. | Immunohistochemical differentiation between type B3 thymomas and thymic squamous cell carcinomas | |
| JP2015507175A5 (enExample) | ||
| Hugen et al. | Circulating tumor cells in genitourinary malignancies: an evolving path to precision medicine | |
| Liu et al. | A machine learning approach yields a multiparameter prognostic marker in liver cancer | |
| Franceschini et al. | Mesothelin in serum and pleural effusion in the diagnosis of malignant pleural mesothelioma with non-positive cytology |